We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+10.95%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$629M
AUM Growth
+$97.2M
Cap. Flow
+$42.9M
Cap. Flow %
6.82%
Top 10 Hldgs %
65.36%
Holding
29
New
3
Increased
8
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$18.8M
2
BMY icon
Bristol-Myers Squibb
BMY
+$18.3M
3
ABT icon
Abbott
ABT
+$14.8M
4
LH icon
Labcorp
LH
+$11.6M
5
ELV icon
Elevance Health
ELV
+$10.1M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$16.7M
2
EXEL icon
Exelixis
EXEL
+$7.75M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$5.93M
4
UTHR icon
United Therapeutics
UTHR
+$5.91M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$5.89M

Sector Composition

Rank Sector Weight
1 Healthcare 98.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
26
United Therapeutics
UTHR
$26.3B
$3.92M 0.62%
28,974
-39,000
-57% -$5.91M
EXEL icon
27
Exelixis
EXEL
$13.9B
– –
-520,091
Closed -$7.75M
MRK icon
28
Merck
MRK
$324B
– –
-297,014
Closed -$16.7M
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-48,500
Closed -$5.93M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q1 2017 Portfolio in Review

As of Q1 2017, Sector Gamma AS held 29 positions worth $629M, up 18% from $532M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sector Gamma AS deployed $42.9M of net new capital in Q1 2017, opening 3 new positions and adding to 8 existing holdings. Its largest new stake was Perrigo: 247,340 shares worth $16.4M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

On the sell side, the largest reduction was United Therapeutics, an estimated $5.91M trimmed.

  • Sector Gamma AS's largest Q1 2017 buy was Perrigo: 247,340 shares worth $16.4M.
  • Sector Gamma AS added most to Bristol-Myers Squibb in Q1 2017, an estimated $18.3M increase.
  • Sector Gamma AS's biggest Q1 2017 reduction was United Therapeutics, cutting an estimated $5.91M.
  • Sector Gamma AS fully exited Merck in Q1 2017, selling an estimated $16.7M.
  • Sector Gamma AS's ten largest holdings make up 65% of its $629M portfolio in Q1 2017.
  • Sector Gamma AS opened 3 new positions and closed 3 in Q1 2017.
  • Sector Gamma AS's portfolio value rose 18% quarter-over-quarter to $629M.

Based on Sector Gamma AS's 13F filing for Q1 2017, filed 12 May 2017.